178 related articles for article (PubMed ID: 31975381)
1. The chromosome 19 microRNA cluster, regulated by promoter hypomethylation, is associated with tumour burden and poor prognosis in patients with hepatocellular carcinoma.
Rui T; Xu S; Zhang X; Huang H; Feng S; Zhan S; Xie H; Zhou L; Ling Q; Zheng S
J Cell Physiol; 2020 Sep; 235(9):6103-6112. PubMed ID: 31975381
[TBL] [Abstract][Full Text] [Related]
2. Expression of C19MC miRNAs in HCC associates with stem-cell features and the cancer-testis genes signature.
Augello C; Colombo F; Terrasi A; Trombetta E; Maggioni M; Porretti L; Rossi G; Guerneri S; Silipigni R; Bosari S; Vaira V
Dig Liver Dis; 2018 Jun; 50(6):583-593. PubMed ID: 29673952
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma.
Augello C; Vaira V; Caruso L; Destro A; Maggioni M; Park YN; Montorsi M; Santambrogio R; Roncalli M; Bosari S
Liver Int; 2012 May; 32(5):772-82. PubMed ID: 22429613
[TBL] [Abstract][Full Text] [Related]
4. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
Lu M; Kong X; Wang H; Huang G; Ye C; He Z
Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
[TBL] [Abstract][Full Text] [Related]
5. Global, cancer-specific microRNA cluster hypomethylation was functionally associated with the development of non-B non-C hepatocellular carcinoma.
Nojima M; Matsui T; Tamori A; Kubo S; Shirabe K; Kimura K; Shimada M; Utsunomiya T; Kondo Y; Iio E; Naito Y; Ochiya T; Tanaka Y
Mol Cancer; 2016 Apr; 15(1):31. PubMed ID: 27137948
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
7. Screening and verification of microRNA promoter methylation sites in hepatocellular carcinoma.
Ni X; Lin Z; Dai S; Chen H; Chen J; Zheng C; Wu B; Ao J; Shi K; Sun H
J Cell Biochem; 2020 Jul; 121(7):3626-3641. PubMed ID: 32065423
[TBL] [Abstract][Full Text] [Related]
8. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
9. Identification by TCGA database search of five genes that are aberrantly expressed and involved in hepatocellular carcinoma potentially via DNA methylation changes.
Matsushita J; Suzuki T; Okamura K; Ichihara G; Nohara K
Environ Health Prev Med; 2020 Jul; 25(1):31. PubMed ID: 32703154
[TBL] [Abstract][Full Text] [Related]
10. Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma.
Liu Z; Dou C; Yao B; Xu M; Ding L; Wang Y; Jia Y; Li Q; Zhang H; Tu K; Song T; Liu Q
Oncotarget; 2016 Jun; 7(24):36909-36923. PubMed ID: 27191994
[TBL] [Abstract][Full Text] [Related]
11. The microRNA cluster C19MC is deregulated in parathyroid tumours.
Vaira V; Elli F; Forno I; Guarnieri V; Verdelli C; Ferrero S; Scillitani A; Vicentini L; Cetani F; Mantovani G; Spada A; Bosari S; Corbetta S
J Mol Endocrinol; 2012 Oct; 49(2):115-24. PubMed ID: 22767050
[TBL] [Abstract][Full Text] [Related]
12. Novel miRNA signature for predicting the stage of hepatocellular carcinoma.
Yerukala Sathipati S; Ho SY
Sci Rep; 2020 Sep; 10(1):14452. PubMed ID: 32879391
[TBL] [Abstract][Full Text] [Related]
13. The regulation of microRNA expression by DNA methylation in hepatocellular carcinoma.
He XX; Kuang SZ; Liao JZ; Xu CR; Chang Y; Wu YL; Gong J; Tian DA; Guo AY; Lin JS
Mol Biosyst; 2015 Feb; 11(2):532-9. PubMed ID: 25424171
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4.
Zhao Y; Li F; Zhang X; Liu A; Qi J; Cui H; Zhao P
Int J Clin Exp Pathol; 2015; 8(10):12446-54. PubMed ID: 26722431
[TBL] [Abstract][Full Text] [Related]
15. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
[TBL] [Abstract][Full Text] [Related]
17. A P53-related microRNA model for predicting the prognosis of hepatocellular carcinoma patients.
Fang SS; Guo JC; Zhang JH; Liu JN; Hong S; Yu B; Gao Y; Hu SP; Liu HZ; Sun L; Zhao Y
J Cell Physiol; 2020 Apr; 235(4):3569-3578. PubMed ID: 31556110
[TBL] [Abstract][Full Text] [Related]
18. A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.
Zhang J; Chong CC; Chen GG; Lai PB
PLoS One; 2015; 10(6):e0128628. PubMed ID: 26046780
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma.
Li BK; Huang PZ; Qiu JL; Liao YD; Hong J; Yuan YF
Diagn Pathol; 2014 Dec; 9():226. PubMed ID: 25466449
[TBL] [Abstract][Full Text] [Related]
20. Low mir-372 expression correlates with poor prognosis and tumor metastasis in hepatocellular carcinoma.
Wu G; Wang Y; Lu X; He H; Liu H; Meng X; Xia S; Zheng K; Liu B
BMC Cancer; 2015 Mar; 15():182. PubMed ID: 25880458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
